DK0901492T3 - Taxanderivater, fremstillingen deraf og formuleringer indeholdende dem - Google Patents

Taxanderivater, fremstillingen deraf og formuleringer indeholdende dem

Info

Publication number
DK0901492T3
DK0901492T3 DK97922918T DK97922918T DK0901492T3 DK 0901492 T3 DK0901492 T3 DK 0901492T3 DK 97922918 T DK97922918 T DK 97922918T DK 97922918 T DK97922918 T DK 97922918T DK 0901492 T3 DK0901492 T3 DK 0901492T3
Authority
DK
Denmark
Prior art keywords
pct
deacetyl
derivatives
preparation
sec
Prior art date
Application number
DK97922918T
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK0901492T3 publication Critical patent/DK0901492T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97922918T 1996-05-10 1997-04-29 Taxanderivater, fremstillingen deraf og formuleringer indeholdende dem DK0901492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000942A IT1283633B1 (it) 1996-05-10 1996-05-10 Derivati tassanici loro sintesi e formulazioni che li contengono
PCT/EP1997/002198 WO1997043291A1 (en) 1996-05-10 1997-04-29 Taxane derivatives, the preparation thereof and formulations containing them

Publications (1)

Publication Number Publication Date
DK0901492T3 true DK0901492T3 (da) 2002-09-02

Family

ID=11374240

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97922918T DK0901492T3 (da) 1996-05-10 1997-04-29 Taxanderivater, fremstillingen deraf og formuleringer indeholdende dem

Country Status (20)

Country Link
US (1) US5955489A (da)
EP (1) EP0901492B1 (da)
JP (1) JP3423002B2 (da)
KR (1) KR100314382B1 (da)
CN (1) CN1097055C (da)
AT (1) ATE220680T1 (da)
AU (1) AU715748B2 (da)
CA (1) CA2253912C (da)
CZ (1) CZ287489B6 (da)
DE (1) DE69714040T2 (da)
DK (1) DK0901492T3 (da)
ES (1) ES2180985T3 (da)
HU (1) HU224965B1 (da)
IT (1) IT1283633B1 (da)
NO (1) NO322266B1 (da)
PL (1) PL185778B1 (da)
PT (1) PT901492E (da)
RU (1) RU2168513C2 (da)
SK (1) SK282471B6 (da)
WO (1) WO1997043291A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤
JP4776843B2 (ja) 1999-10-01 2011-09-21 イムノゲン インコーポレーティッド 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
ITMI20012185A1 (it) 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20012186A1 (it) 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
WO2006122408A1 (en) 2005-05-18 2006-11-23 Aegera Therapeutics Inc. Bir domain binding compounds
BRPI0711591A2 (pt) 2006-05-16 2011-11-16 Aegera Therapeutics, Inc. composto de ligação de domìnio bir da iap
EP2080764B1 (en) 2008-01-18 2012-08-22 INDENA S.p.A. Solid forms of ortataxel
NZ602368A (en) 2010-02-12 2014-10-31 Pharmascience Inc Iap bir domain binding compounds
CN113603660B (zh) * 2021-09-02 2024-01-05 无锡紫杉药业有限公司 一种10-羰基多西他赛的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601785B1 (fr) * 1986-07-15 1989-07-28 Telecommunications Sa Dispositif de reserve pour cable a fibre optique et le procede de mise en oeuvre
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5393886A (en) * 1993-05-05 1995-02-28 The Du Pont Merck Pharmaceutical Company Intermediates for the synthesis of anthrapyrazolone anticancer agents
IT1275936B1 (it) * 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
IT1275435B (it) * 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono

Also Published As

Publication number Publication date
ATE220680T1 (de) 2002-08-15
NO322266B1 (no) 2006-09-04
PL185778B1 (pl) 2003-07-31
AU715748B2 (en) 2000-02-10
EP0901492B1 (en) 2002-07-17
SK153998A3 (en) 1999-04-13
WO1997043291A1 (en) 1997-11-20
CA2253912C (en) 2006-03-28
IT1283633B1 (it) 1998-04-23
CN1097055C (zh) 2002-12-25
HK1019603A1 (en) 2000-02-18
CA2253912A1 (en) 1997-11-20
ITMI960942A0 (da) 1996-05-10
NO985187L (no) 1998-11-06
CZ287489B6 (en) 2000-12-13
EP0901492A1 (en) 1999-03-17
PT901492E (pt) 2002-10-31
JP3423002B2 (ja) 2003-07-07
CZ361998A3 (cs) 1999-06-16
RU2168513C2 (ru) 2001-06-10
NO985187D0 (no) 1998-11-06
JP2000513716A (ja) 2000-10-17
PL329768A1 (en) 1999-04-12
ES2180985T3 (es) 2003-02-16
US5955489A (en) 1999-09-21
CN1218475A (zh) 1999-06-02
ITMI960942A1 (it) 1997-11-10
SK282471B6 (sk) 2002-02-05
HU224965B1 (en) 2006-04-28
DE69714040D1 (de) 2002-08-22
HUP9903649A3 (en) 2001-06-28
KR100314382B1 (ko) 2002-02-28
AU2888697A (en) 1997-12-05
DE69714040T2 (de) 2003-03-13
HUP9903649A2 (hu) 2001-05-28
KR20000010894A (ko) 2000-02-25

Similar Documents

Publication Publication Date Title
ZA924527B (en) Azanorbornane derivatives
GR3021411T3 (en) Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles.
IL108769A0 (en) Spirocyclic piperidine derivatives
SG55184A1 (en) New imidazopyridines
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
NO985187D0 (no) Taxanderivater, deres fremstilling og formuleringer som inneholder dem
PL314181A1 (en) Phenylindole compounds
NO923226L (no) Nytt beta-fenylisoserinderivat, dets fremstilling og anvendelse
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
DK0675895T3 (da) Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling
DK0918754T3 (da) Anthranilsyrediamidderivater, fremstilling og farmaceutisk anvendelse deraf som antigastrinmidler
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them